epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

creatine ethyl ester HCl

creatine

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • amyotrophic lateral sclerosis [Possibly Ineffective]
  • arsenic poisoning [Insufficient Evidence]
  • athletic performance [Possibly Effective]
  • cerebral creatine deficiency syndromes [Possibly Effective]
  • CHF [Insufficient Evidence]
  • chronic fatigue syndrome [Insufficient Evidence]
  • CKD [Insufficient Evidence]
  • cognitive decline, age-related [Insufficient Evidence]
  • cognitive function [Insufficient Evidence]
  • COPD [Insufficient Evidence]
  • depression [Insufficient Evidence]
  • diabetes mellitus, type 2 [Insufficient Evidence]
  • fatigue [Insufficient Evidence]
  • fatigue, post-stroke [Insufficient Evidence]
  • fibromyalgia [Insufficient Evidence]
  • gyrate atrophy [Insufficient Evidence]
  • hereditary motor and sensory neuropathy [Insufficient Evidence]
  • Huntington disease [Possibly Ineffective]
  • hyperhomocysteinemia [Insufficient Evidence]
  • idiopathic inflammatory myopathies [Insufficient Evidence]
  • juvenile idiopathic arthritis [Insufficient Evidence]
  • McArdle disease [Insufficient Evidence]
  • memory [Insufficient Evidence]
  • mitochondrial myopathies [Insufficient Evidence]
  • multiple sclerosis [Insufficient Evidence]
  • muscle breakdown [Insufficient Evidence]
  • muscle cramps [Insufficient Evidence]
  • muscle strength [Possibly Effective]
  • muscle wasting, HIV/AIDS-related [Insufficient Evidence]
  • muscular dystrophy [Insufficient Evidence]
  • neonatal apnea [Insufficient Evidence]
  • osteoarthritis [Insufficient Evidence]
  • osteopenia [Possibly Ineffective]
  • Parkinson disease [Insufficient Evidence]
  • peripheral arterial disease [Insufficient Evidence]
  • physical performance [Insufficient Evidence]
  • postop recovery [Insufficient Evidence]
  • Rett syndrome [Insufficient Evidence]
  • rheumatoid arthritis [Insufficient Evidence]
  • sarcopenia [Possibly Effective]
  • schizophrenia [Insufficient Evidence]
  • skin aging [Insufficient Evidence]
  • sleep deprivation [Insufficient Evidence]
  • spinal cord injury [Insufficient Evidence]
  • spinal muscular atrophy [Insufficient Evidence]
  • traumatic brain injury [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information